Jianjin Huang

745 citations
25 papers · 338 indexed · h-index 11
Topics
Lung Cancer Treatments and Mutations (10 papers)Colorectal Cancer Treatments and Studies (6 papers)Lung Cancer Research Studies (6 papers)

In The Last Decade

Jianjin Huang

25 papers receiving 333 citations

Peers

Jianjin Huang
Comparison fields: 5 of 62
  • Molecular Biology 134
  • Oncology 117
  • Pulmonary and Respiratory Medicine 105
  • Cancer Research 81
  • Surgery 44
Replace Liangyu Bie with:
Liangyu Bie China
Chengzhi Huang China
Marta Briarava Italy
Petros Giovanis Italy
Annalisa Lorenzato Italy
Joung Eun Lim South Korea
Samira Syed United States
Bok‐Soon Lee South Korea
Jiqing Hao China
Jianjin Huang relative to Liangyu Bie China Liangyu Bie's profile →
Citations per field
00.5×2.6×
Liangyu Bie · 1×
Citations per year

Countries citing papers authored by Jianjin Huang

Since Specialization
Citations

This map shows the geographic impact of Jianjin Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjin Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjin Huang more than expected).

Fields of papers citing papers by Jianjin Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjin Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjin Huang. The network helps show where Jianjin Huang may publish in the future.

Co-authorship network of co-authors of Jianjin Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Jianjin Huang. A scholar is included among the top collaborators of Jianjin Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjin Huang. Jianjin Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 31
3 51
4 7
5 1
6 4
7 6
8 6
9 32
10 2
11 31
12 14
13 39
14 6
15 11
16 13
17 20
18 21
19
Effect of Diyushengbai Tablet on Blood Cell Decreasing During Chemotherapy of Non-small Cell Lung Cancer
1
20 2

About Jianjin Huang

Jianjin Huang is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 338 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (6 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Cancer Research (81 citations), Oncology (117 citations) and Pulmonary and Respiratory Medicine (105 citations). Jianjin Huang has collaborated with scholars based in China, Taiwan and United Kingdom. Frequent co-authors include Pan Chi, Ling Ding, Shu Zheng, Jianzhen Shan, Yanyan Xuan, Qi Zhang, Hanguang Hu, Hao Liu, Ying Dong and Shaojun Yu. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026